Showing results (861-870 of 1,206) with videos related to

Sort By:
Pageof 121
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JACC. Cardiovascular Interventions|November 6, 2020
Optimal Fluoroscopic Projections of Coronary Ostia and Bifurcations Defined by Computed Tomographic Coronary AngiographyViktor Kočka, Pascal Thériault-Lauzier, Tian-Yuan Xiong, et al.
International Journal of Cardiology|September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trialChao Gao, Kuniaki Takahashi, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 13, 2015
Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individualsHans Reiser, Roland Klingenberg, Danielle Hof, et al.
International Journal of Cardiology|April 26, 2018
Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysisLaura S Kerkmeijer, Bimmer E Claessen, Usman Baber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
Lancet (London, England)|November 4, 2016
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialPatrick W Serruys, Bernard Chevalier, Yohei Sotomi, et al.
Lancet (London, England)|March 15, 2017
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsFrancesco Costa, David van Klaveren, Stefan James, et al.
Circulation|October 18, 2021
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart DiseasePaolo Calabrò, Felice Gragnano, Giampaolo Niccoli, et al.
Pageof 121